26 Apr 2016 10:28
(ShareCast News) - Horizon Discovery Group's bioproduction business has signed a license agreement with LakePharma over the commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line. Horizon's Chief Executive Dr Darrin Disley said the agreement serves as recognition and valida
Read more